These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36804858)

  • 1. Conduction system disease in cardiac amyloidosis.
    Assaf A; Mekhael M; Noujaim C; Chouman N; Younes H; Kreidieh O; Marrouche N; Donnellan E
    Trends Cardiovasc Med; 2024 May; 34(4):250-253. PubMed ID: 36804858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of atrial sensing for new-onset atrial arrhythmias diagnosis and management in single-chamber implantable cardioverter-defibrillator recipients: Results from the THINGS registry.
    Biffi M; Iori M; De Maria E; Bolognesi MG; Placci A; Calvi V; Allocca G; Ammendola E; Carinci V; Boggian G; Saporito D; Grassini D; Giacopelli D; Statuto G; Ziacchi M
    J Cardiovasc Electrophysiol; 2020 Apr; 31(4):846-853. PubMed ID: 32064713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ICD triple counting leading to a lethal inappropriate shock.
    Korantzopoulos P; Manolis G; Manolis AG
    J Cardiovasc Electrophysiol; 2020 Jan; 31(1):231-233. PubMed ID: 31778244
    [No Abstract]   [Full Text] [Related]  

  • 4. Indexed left ventricular mass to QRS voltage ratio is associated with heart failure hospitalizations in patients with cardiac amyloidosis.
    Slivnick JA; Wallner AL; Vallakati A; Truong VT; Mazur W; Elamin MB; Tong MS; Raman SV; Zareba KM
    Int J Cardiovasc Imaging; 2021 Mar; 37(3):1043-1051. PubMed ID: 33068247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of ventricular interval during atrial fibrillation by atrioventricular node vagal stimulation: chronic clinical atrioventricular-nodal stimulation download study.
    Bianchi S; Rossi P; Schauerte P; Elvan A; Blomström-Lundqvist C; Kornet L; Gal P; Mörtsell D; Wouters G; Gemein C
    Circ Arrhythm Electrophysiol; 2015 Jun; 8(3):562-8. PubMed ID: 25878323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial fibrillation in patients with implantable defibrillators.
    Sakhuja R; Shah AJ; Keebler M; Thakur RK
    Cardiol Clin; 2009 Feb; 27(1):151-61, ix-x. PubMed ID: 19111771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inappropriate ICD shocks do not induce pro-arrhythmic electrocardiographic changes in men.
    Vandenberk B; Hnatkova K; Goovaerts G; Garweg C; Ector J; Van Huffel S; Malik M; Willems R
    Scand Cardiovasc J; 2017 Feb; 51(1):47-52. PubMed ID: 27268510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of implantable cardioverter defibrillator in nonischaemic cardiomyopathy: a U-turn?
    Gaita F; Castagno D; Anselmino M
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e63-e67. PubMed ID: 29084020
    [No Abstract]   [Full Text] [Related]  

  • 9. Differences in predictors of implantable cardioverter-defibrillator therapies in patients with ischaemic and non-ischaemic cardiomyopathies.
    Darma A; Nedios S; Kosiuk J; Richter S; Doering M; Arya A; Rolf S; Sommer P; Hindricks G; Bollmann A
    Europace; 2016 Mar; 18(3):405-12. PubMed ID: 26056190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Arrhythmias in Cardiac Amyloidosis.
    Giancaterino S; Urey MA; Darden D; Hsu JC
    JACC Clin Electrophysiol; 2020 Apr; 6(4):351-361. PubMed ID: 32327068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac Implantable Electronic Devices: A Window Into the Evolution of Conduction Disease in Cardiac Amyloidosis.
    Rehorn MR; Loungani RS; Black-Maier E; Coniglio AC; Karra R; Pokorney SD; Khouri MG
    JACC Clin Electrophysiol; 2020 Sep; 6(9):1144-1154. PubMed ID: 32972550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological Manifestations of Cardiac Amyloidosis:
    Hartnett J; Jaber W; Maurer M; Sperry B; Hanna M; Collier P; Patel DR; Wazni OM; Donnellan E
    JACC CardioOncol; 2021 Oct; 3(4):506-515. PubMed ID: 34729522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Detection of Symptomatic Paroxysmal Cardiac Arrhythmias by Trans-Telephonic ECG Monitoring: Impact on Diagnosis and Treatment of Atrial Fibrillation.
    Anczykowski J; Willems S; Hoffmann BA; Meinertz T; Blankenberg S; Patten M
    J Cardiovasc Electrophysiol; 2016 Sep; 27(9):1032-7. PubMed ID: 27257094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation increases the risk of recurrent ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients.
    Rusnak J; Behnes M; Reiser L; Schupp T; Bollow A; Reichelt T; Borggrefe M; Ellguth D; Engelke N; El-Battrawy I; Ansari U; Barre M; Weidner K; Müller J; Barth C; Meininghaus DG; Akin M; Bertsch T; Taton G; Akin I
    Arch Cardiovasc Dis; 2021; 114(6-7):443-454. PubMed ID: 33967015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable cardiac electronic device therapy for patients with a systemic right ventricle.
    Barracano R; Brida M; Guarguagli S; Palmieri R; Diller GP; Gatzoulis MA; Wong T
    Heart; 2020 Jul; 106(14):1052-1058. PubMed ID: 32269130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Impact of a Chronic Total Coronary Occlusion on Ventricular Arrhythmias and Long-Term Mortality in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator (the eCTOpy-in-ICD Study).
    van Dongen IM; Yilmaz D; Elias J; Claessen BEPM; Delewi R; Knops RE; Wilde AAM; van Erven L; Schalij MJ; Henriques JPS
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29720502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrocardiographic features and rhythm disorders in cardiac amyloidosis.
    Martini N; Sinigiani G; De Michieli L; Mussinelli R; Perazzolo Marra M; Iliceto S; Zorzi A; Perlini S; Corrado D; Cipriani A
    Trends Cardiovasc Med; 2024 May; 34(4):257-264. PubMed ID: 36841466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Outcomes and Characteristics With Dofetilide in Atrial Fibrillation Patients Considered for Implantable Cardioverter-Defibrillator.
    Koene RJ; Menon V; Cantillon DJ; Dresing TJ; Martin DO; Kanj M; Saliba WI; Tarakji KG; Baranowski B; Hussein AA; Tchou PJ; Bhargava M; Callahan TD; Rickard JW; Niebauer MJ; Chung MK; Varma N; Wilkoff BL; Lindsay BD; Wazni OM
    Circ Arrhythm Electrophysiol; 2020 Jul; 13(7):e008168. PubMed ID: 32538135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis.
    Varr BC; Zarafshar S; Coakley T; Liedtke M; Lafayette RA; Arai S; Schrier SL; Witteles RM
    Heart Rhythm; 2014 Jan; 11(1):158-62. PubMed ID: 24121001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.